PeptideStack
5.2kquestions
20kanswers
220users

Is 2.5 mg in 0.5 mL of 0.9% sodium chloride a sensible presentation for cagrilintide?

Asked 21 Feb 2025Modified 13 months agoViewed 12k times
5

Concretely: 2.5 mg · 0.5 mL · 0.9% sodium chloride · cagrilintide.

The failure mode I am trying to avoid is making this decision emotionally.

I have twelve months in view and I would like the plan to survive that long.

What would you do, and what would make you change course?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
RI
askedrukhsana_iqbal14k2821 Feb 2025
2Does this hold at lower concentrations, or does adsorption dominate? – Dr_Nadia_Farsi 7 months ago
Worth flagging that this changed in 2025, so older answers on the site are out of date. – low_dead_space 5 months ago
add a comment

5 Answers

Sorted by votes
52

The single most useful thing to do is write the arithmetic on the vial label, because you will reconstruct it from memory at an inconvenient moment if you do not.

Number of stopper piercings matters less than the gauge doing the piercing. A 30G or 31G needle through a butyl stopper leaves a track that reseals; a 21G or 18G drawing needle punches a core and can drop it into the solution.

Reading a lyophilised cake

AppearanceInterpretationAction
Intact opaque puck, proud of baseCycle ran correctlyProceed
Slumped to one sideShipped before fully dry, or vibrationUsually usable; note it
Glassy translucent filmCollapse above glass transitionTest before use
Melt-back ring at stopperThermal excursion in transitTest before use
No visible cake at allVery low fill, or nothing thereWeigh it; query the supplier

The concentration you actually work with is label claim times content fraction divided by actual diluent volume, which is usually not the same as the nominal concentration because content is usually not 100 per cent and you rarely measure the diluent volume to 0.1 mL precision.

Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.

Worth noting: the concentration after reconstitution is not the same as the label claim, and most people do not account for the difference.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
CL
answeredcold_lane14k1819 Jun 2025
7Does this hold at lower concentrations, or does adsorption dominate? – marta_okonkwo 7 months ago
6Worth flagging that this changed in 2025, so older answers on the site are out of date. – kirsi_lahtinen 5 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
34

The answer depends on exactly which dose and which vial you are asking about, but the method is always the same.

Breaking it down further: if a 10 mg vial has 96.5 per cent content, you have 9.65 mg of peptide. Divide that by 2.00 mL and your concentration is 4.825 mg/mL, not 5.00 mg/mL, which is a 3.5 per cent systematic error in every dose calculation.

Worked example, because the general form is easier to trust once you have seen it once. Take a 10 mg vial and add 2 mL of diluent: the concentration is 10 ÷ 2 = 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL. On a U-100 syringe, where 1 unit = 0.01 mL, that is 0.1 ÷ 0.01 = 10 units. Change the diluent to 1 mL and the same dose becomes 5 units — same dose, half the resolution.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.

shareimprove this answerflag
DV
answereddead_volume49k383 Mar 2025
7Any reason this would differ for a longer peptide? – rota_site 8 months ago
add a comment
25

Work in the order concentration, then volume, then units, and the arithmetic stops being confusing. Concentration is milligrams per millilitre and comes from the vial contents and the diluent volume. Volume per dose is dose divided by concentration. Units on a U-100 syringe are volume in millilitres multiplied by one hundred.

On filtration: a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide onto the membrane — with a low-binding PVDF or PES membrane the loss is typically a few per cent.

Do not use the same needle to pierce the stopper and to administer. The tip is blunted by the stopper, and the hub now contains a dose you are about to lose to dead space anyway.

The content assay results from major testing services show that nominal vial claim and measured content differ by one to ten per cent, making content a driver of dose error.

If in doubt, use more diluent and accept the shorter usable window.

edited 8 Jun 2025 by mz_4113 — expanded the table to cover the lower concentration

shareimprove this answerflag
M4
answeredmz_411399k25828 May 2025
19

This is arithmetic, so let us do the arithmetic rather than argue about it.

Dead space quantified: a fixed-needle insulin syringe holds roughly 3 to 5 µL in the hub and needle after the plunger bottoms out. A luer-lock syringe with a detachable needle holds 35 to 100 µL depending on the hub design. At 5 mg/mL that is 15 to 25 µg lost per draw on the insulin syringe and 175 to 500 µg on the luer-lock — which over ten draws is the difference between losing a rounding error and losing half a milligram.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
HV
answeredh_villanueva50k388 Jun 2025
3Useful. I have added the accept threshold suggestion to my own notes. – amara_nwachukwu 37 days ago
add a comment
16

The distinction that resolves most of these questions is understanding what concentration actually means and why it is not the same as label claim.

Rotation of injection site is a tolerability measure, not a pharmacokinetic one, but if you are going to do it you might as well do it right.

The insulin-unit standard U-100 means 100 units per millilitre, so one unit is 0.01 mL — this is the conversion that trips up more people here than any other single piece of arithmetic.

The limitation is that technique reduces risk, it does not remove it, and nothing you can do outside a controlled environment makes a non-sterile preparation sterile.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.

edited 23 Apr 2025 by ines_brandt — added a caveat about sampling

shareimprove this answerflag
IB
answeredines_brandt93k2485 Apr 2025
3For what it is worth, my own result was within half a per cent of this. – lipid_panel_q 3 months ago
2Any reason this would differ for a longer peptide? – haze_check 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.